EDSA - Company ID 0001540159
The table below shows Edesa Biotech, Inc.'s income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | $0.00 | $328.80K |
| Cost of revenue | - | - | - | - | $0.00 | $17.60K |
| Gross profit | - | - | - | - | - | - |
| R&D | $3.67M | $2.88M | $4.79M | $13.34M | $17.95M | $3.33M |
| SG&A |
Edesa Biotech, Inc. reported annual revenue of $0.00 for fiscal year 2021. That is down 100.0% from $328.80K in fiscal 2020. Over the 9 fiscal years shown, annual revenue declined from $286.05K (FY 2012) to $0.00. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $4.24M |
| $4.13M |
| $4.43M |
| $5.04M |
| $5.73M |
| $3.38M |
| Operating income | -$7.91M | -$7.01M | -$9.22M | -$18.37M | -$23.68M | -$6.40M |
| Income tax | $800.00 | $800.00 | $800.00 | $800.00 | $800.00 | $800.00 |
| Net income | -$7.19M | -$6.17M | -$8.37M | -$17.55M | -$13.34M | -$6.36M |
| EPS (diluted) | - | - | - | - | - | - |